, Rising Incidence of Hepatocellular Carcinoma in the United States, New England Journal of Medicine, vol.340, issue.10, pp.745-750, 1999.
DOI : 10.1056/NEJM199903113401001
, Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes, Gastroenterology, vol.138, issue.1, pp.52-64, 2010.
DOI : 10.1053/j.gastro.2009.09.006
, Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival, Hepatology, vol.74, issue.5, pp.1741-1749, 2010.
DOI : 10.1016/j.ijrobp.2008.10.005
URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.23944/pdf
, Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study, Hepatology, vol.56, issue.5, pp.1826-1837, 2013.
DOI : 10.1016/j.jhep.2011.07.012
URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.26014/pdf
, Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation, Hepatology, vol.140, issue.21 Suppl. 5, pp.868-878, 2011.
DOI : 10.1053/j.gastro.2010.10.049
URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.24451/pdf
, Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.9, issue.8, pp.59-64, 2010.
DOI : 10.1111/j.1600-6143.2009.02695.x
URL : https://academic.oup.com/annonc/article-pdf/21/suppl_5/v59/479194/mdq166.pdf
, Radioembolization for hepatocellular carcinoma, Journal of Hepatology, vol.56, issue.2, pp.464-473, 2012.
DOI : 10.1016/j.jhep.2011.07.012
, Patient Selection and Activity Planning Guide for Selective Internal Radiotherapy With Yttrium-90 Resin Microspheres, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.1, pp.401-407, 2012.
DOI : 10.1016/j.ijrobp.2010.08.015
, TheraSphere TM yttrium-90 glass microsphere instruction for use. https://www.btg-im.com/getattachment
, Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with 90Y microspheres: the experience of the National Tumor Institute of Milan, Q J Nucl Med Mol Imaging, vol.55, pp.168-197, 2011.
, Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results, Journal of Nuclear Medicine, vol.53, issue.2, pp.255-263, 2012.
DOI : 10.2967/jnumed.111.094235
URL : https://hal.archives-ouvertes.fr/hal-00866987
, Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations, Journal of Nuclear Medicine, vol.51, issue.9, pp.1377-1385, 2010.
DOI : 10.2967/jnumed.110.075861
URL : http://jnm.snmjournals.org/content/51/9/1377.full.pdf
, Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept, European Journal of Nuclear Medicine and Molecular Imaging, vol.52, issue.12, pp.1057-1068, 2013.
DOI : 10.2967/jnumed.111.095232
URL : http://doi.org/10.1007/s00259-013-2395-x
, Personalized Dosimetry with Intensification Using 90Y-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis, Journal of Nuclear Medicine, vol.56, issue.3, pp.339-346, 2015.
DOI : 10.2967/jnumed.114.145177
URL : https://hal.archives-ouvertes.fr/hal-01128116
, Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus, Annals of Surgical Oncology, vol.240, issue.8, pp.2073-2080, 2010.
DOI : 10.3748/wjg.v12.i47.7561
, Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology, European Journal of Nuclear Medicine and Molecular Imaging, vol.54, issue.7, pp.1718-1738, 2015.
DOI : 10.2967/jnumed.112.117614
, Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study, British Journal of Cancer, vol.70, issue.5, pp.994-999, 1994.
DOI : 10.1038/bjc.1994.436
URL : http://www.nature.com/bjc/journal/v70/n5/pdf/bjc1994436a.pdf
, Predictive Value of Intratumoral 99mTc-Macroaggregated Albumin Uptake in Patients with Colorectal Liver Metastases Scheduled for Radioembolization with 90Y-Microspheres, Journal of Nuclear Medicine, vol.54, issue.4, pp.516-522, 2013.
DOI : 10.2967/jnumed.112.112508
URL : http://jnm.snmjournals.org/content/54/4/516.full.pdf
, Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors, Journal of Nuclear Medicine, vol.56, issue.11, pp.1654-1660, 2015.
DOI : 10.2967/jnumed.115.162685
, Clinical impact of 99m Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90 Y-loaded microspheres, Eur J Nucl Med Mol Imaging, vol.43, pp.824-831, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01197349
, High Impact of Preferential Flow on 99mTc-MAA and 90Y-Loaded Microsphere Uptake Correlation, Journal of Nuclear Medicine, vol.57, issue.11, pp.1829-1830, 2016.
DOI : 10.2967/jnumed.116.175943
URL : https://hal.archives-ouvertes.fr/hal-01396193
, The Low Hepatic Toxicity per Gray of 90Y Glass Microspheres Is Linked to Their Transport in the Arterial Tree Favoring a Nonuniform Trapping as Observed in Posttherapy PET Imaging, Journal of Nuclear Medicine, vol.55, issue.1, pp.135-140, 2014.
DOI : 10.2967/jnumed.113.126839
, Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial, Journal of Hepatology, vol.57, issue.4, pp.821-829, 2012.
DOI : 10.1016/j.jhep.2012.06.014